A purification scheme to maximize the efficiency of the purification process and product purity while minimizing the development time for early-phase therapeutic antibodies.
Natarajan Ramasubramanyan, PhD
Advertisement
Natarajan Ramasubramanyan, PhD, is an associate research fellow at Pfizer Global Research and Development Global Biologics, Bioprocess R&D
Articles by Natarajan Ramasubramanyan, PhD
A purification scheme to maximize the efficiency of the purification process and product purity while minimizing the development time for early-phase therapeutic antibodies.
Advertisement
Latest Updated Articles
Advertisement
Advertisement